Rare diseases
Investigational molecules
Locations
Recruiting trials first
4 clinical trials in this condition
Italy
AustriaAustria
GermanyIn short
Lung adenocarcinoma is the most common type of lung cancer diagnosed today, and getting the right diagnosis at the right time can make a significant difference in your treatment options and outcomes.
If you have symptoms that could be related to lung problems, it's important to talk to your doctor about whether you need diagnostic testing. Lung adenocarcinoma is a form of non-small cell lung cancer, which means it's part of a larger group of lung cancers that behave differently from small cell lung cancer. This type of cancer begins in the glandular cells of the lungs—the cells that produce mucus and other fluids—and it usually develops in the outer parts of the lungs rather than the central airways.
You should consider seeking diagnostic evaluation if you experience a persistent cough that doesn't go away or seems to be getting worse over time, especially if you've been coughing for several weeks without improvement. Shortness of breath, chest pain that may worsen when you breathe deeply or cough, and coughing up blood or rust-colored phlegm are all signs that warrant medical attention. Some people also notice unexplained weight loss, feeling extremely tired without a clear reason, or a hoarse voice that persists.
While smoking tobacco is the leading risk factor for lung adenocarcinoma, this particular type of lung cancer is also the most common form seen in people who have never smoked. It's especially prevalent among women and younger individuals compared to other lung cancer types. This means that even if you've never touched a cigarette, you shouldn't dismiss symptoms that could indicate lung problems. If you have a family history of lung cancer or have been exposed to substances like asbestos, radon, silica, or heavy metals through your work, your doctor may recommend earlier or more frequent testing.
For people who smoke or used to smoke heavily, screening is recommended even before symptoms appear. If you're age 50 or older and have smoked heavily for many years, or if you quit within the past 15 years, you should discuss lung cancer screening with your healthcare provider. This type of early detection can find cancer when it's smaller and hasn't spread yet, which generally means better treatment outcomes.
When your doctor suspects lung adenocarcinoma, several different types of tests will be used to confirm whether cancer is present, determine exactly what type it is, and understand how far it has spread. The diagnostic process usually starts with simpler imaging tests and progresses to more detailed examinations if needed.
The first step in diagnosing lung adenocarcinoma is often a chest X-ray. This is a quick and straightforward test that creates pictures of your lungs and can reveal abnormal areas or masses. However, X-rays don't always show small tumors or provide enough detail, so additional imaging is usually necessary.
A CT scan (computed tomography scan) is a more detailed imaging test that takes multiple X-ray pictures from different angles and combines them to create cross-sectional images of your lungs. CT scans can show the size and location of a tumor much more clearly than regular X-rays. They can also reveal whether cancer has spread to lymph nodes or other parts of your chest. For screening in high-risk individuals, doctors use a special type called a low-dose CT scan, which uses less radiation while still providing clear images.
An MRI scan (magnetic resonance imaging) uses magnets and radio waves instead of radiation to create detailed pictures of your body's soft tissues. While MRI is less commonly used than CT for lung cancer, it can be helpful in certain situations, such as determining whether cancer has spread to the brain or spinal cord.
A PET scan (positron emission tomography) involves injecting a small amount of radioactive sugar into your bloodstream. Cancer cells absorb more of this sugar than normal cells, so they show up brighter on the scan images. PET scans are particularly useful for seeing whether cancer has spread to other parts of your body. Often, a PET scan is combined with a CT scan in a single test called a PET-CT scan.
Testing your sputum—the mucus you cough up from your lungs—can sometimes reveal cancer cells. If you're coughing up sputum regularly, your doctor may collect samples to examine under a microscope. This test is called sputum cytology. While it's a simple and non-invasive test, it doesn't always detect cancer cells, especially if the tumor is located in the outer parts of the lungs where adenocarcinoma typically develops.
To definitively diagnose lung adenocarcinoma, doctors need to obtain a sample of tissue from the suspicious area in your lung. This procedure is called a biopsy, and it's the only way to confirm that cancer is present and determine what specific type it is. There are several different ways to perform a lung biopsy, and your doctor will choose the method based on where the tumor is located and your overall health.
During a bronchoscopy, a thin, flexible tube with a light and camera on the end is inserted through your mouth or nose and guided down into your airways. The doctor can see inside your lungs and use small instruments passed through the bronchoscope to take tissue samples. You'll be sedated during this procedure to keep you comfortable. Bronchoscopy works best for tumors located in or near the central airways.
For tumors in the outer parts of the lungs, a needle biopsy may be performed. Using CT scan images as a guide, the doctor inserts a thin needle through your chest wall and into the lung to remove a small piece of tissue. This is called a CT-guided needle biopsy or transthoracic needle biopsy. You'll receive local anesthesia to numb the area, and you may feel pressure but shouldn't feel significant pain during the procedure.
In some cases, if the cancer is suspected to have spread to nearby lymph nodes, a mediastinoscopy may be performed. This is a surgical procedure done under general anesthesia where the doctor makes a small incision at the base of your neck and inserts a thin tube to examine and sample lymph nodes in the area between your lungs.
Once the biopsy confirms that you have lung adenocarcinoma, additional specialized testing will be done on the cancer cells themselves. This is called biomarker testing or molecular testing, and it looks for specific genetic changes or mutations in the cancer cells. These tests are extremely important because they help your doctor understand the unique characteristics of your cancer and determine which treatments are most likely to work for you.
The tissue samples are sent to a specialized laboratory where scientists examine the DNA and proteins in the cancer cells. They're looking for specific alterations in genes such as EGFR, ALK, ROS1, KRAS, and others. Finding one of these changes can mean that you're eligible for targeted therapy—medications specifically designed to attack cancer cells with those particular genetic alterations. This testing can take one to two weeks to complete, but the wait is worthwhile because it provides crucial information for planning your treatment.
After confirming the diagnosis, your medical team needs to determine the stage of your cancer—in other words, how large the tumor is and whether it has spread beyond the original location in your lung. Staging helps guide treatment decisions and gives you and your doctors a better understanding of what to expect.
Many of the same imaging tests used for diagnosis are also used for staging. Additional tests might include imaging of your brain with an MRI or CT scan, and bone scans to check whether cancer has spread to your bones. Blood tests can provide information about your overall health and organ function, which is important for planning treatment.
Lung adenocarcinoma is staged from 0 to IV, with Stage 0 being the earliest (cancer only in the top lining of the lung) and Stage IV meaning the cancer has spread to other organs or the fluid around the lungs or heart. Understanding your stage helps your treatment team develop the best plan for your situation.
If you're considering participating in a clinical trial—a research study testing new treatments—you'll need to undergo specific diagnostic tests to determine whether you're eligible. Clinical trials have strict criteria about who can participate, and these requirements exist to ensure patient safety and to help researchers get clear answers about whether a treatment works.
For most lung cancer clinical trials, you'll need documentation of your diagnosis confirmed through biopsy and pathology reports showing that you have lung adenocarcinoma. The pathology report must clearly state the specific type of non-small cell lung cancer and any biomarker test results. Many trials require that your tumor has specific genetic mutations or protein markers, so comprehensive biomarker testing is essential before you can be considered for these studies.
Clinical trials typically require recent imaging studies—usually within the past few weeks—to establish baseline measurements of your tumors. These images will be compared to later scans to see whether the experimental treatment is working. You'll likely need CT scans of your chest and abdomen, and possibly PET scans, brain imaging, and bone scans depending on the trial's requirements and your cancer's stage.
Blood tests are a standard part of trial qualification. Researchers need to verify that your organs, particularly your kidneys, liver, and bone marrow, are functioning well enough to handle the investigational treatment. Tests will measure things like your red blood cell count, white blood cell count, platelets, kidney function, and liver enzymes. Your heart function may also be evaluated through an electrocardiogram (ECG) or echocardiogram, especially if the experimental treatment could potentially affect the heart.
Performance status assessment is another qualification criterion. This involves your doctor evaluating how well you're able to carry out daily activities and how much the cancer is affecting your physical functioning. Most trials require that you're able to take care of yourself and spend at least some time out of bed each day. This assessment helps ensure that you're strong enough to tolerate the experimental treatment.
Some trials require fresh tumor biopsies, even if you had one previously for diagnosis. This is because researchers want to study the tumor tissue using the most current techniques or need fresh samples for specific laboratory analyses. While having another biopsy can feel burdensome, the information gained can be valuable for both your care and advancing scientific knowledge.
Documentation of previous treatments is crucial for trial eligibility. Trials often specify whether participants must be newly diagnosed with no prior treatment, or whether they must have tried and progressed through specific standard treatments first. You'll need detailed records of any previous chemotherapy, radiation, surgery, or other therapies you've received.
Throughout your participation in a clinical trial, you'll undergo regular diagnostic tests to monitor how you're responding to the treatment and to watch for any side effects. These often include imaging scans every few weeks or months, frequent blood tests, and assessments of symptoms and quality of life. While this means more appointments and tests than you might have with standard treatment, the close monitoring ensures your safety and provides valuable data about the experimental therapy.
The outlook for people with lung adenocarcinoma depends on several important factors. The stage at which the cancer is discovered has the most significant impact—cancers found early, before they've spread beyond the lung, generally have much better outcomes than those discovered at advanced stages. Only about one-third of lung adenocarcinomas are diagnosed at Stage I, when treatment is most effective. The size of the tumor, whether cancer has spread to lymph nodes, and whether it has reached distant organs all influence prognosis.
Your overall health and ability to tolerate treatment also affect your prognosis. People who are otherwise healthy and can undergo aggressive treatment often have better outcomes. The specific genetic characteristics of your tumor, identified through biomarker testing, can significantly influence prognosis as well—some mutations respond exceptionally well to targeted therapies, leading to improved outcomes. Adenocarcinoma tends to grow more slowly than other types of lung cancer, and because it's often found in the outer parts of the lungs, it may be discovered before spreading, which can improve the chances of successful treatment.
Lung cancer remains a serious disease, and despite advances in treatment, the five-year survival rate for all lung cancers combined is less than 12% to 15%. However, this statistic includes all types and stages of lung cancer, and individual outcomes can vary dramatically based on the factors mentioned above. People diagnosed with early-stage disease who receive appropriate treatment have significantly better survival rates than those diagnosed at advanced stages. Lung adenocarcinoma that is found before it has spread outside the lung has a much more favorable prognosis than cancer that has metastasized to other organs.
It's important to understand that survival statistics are based on large groups of people and represent averages from past years. They cannot predict what will happen in your individual case, and new treatments continue to improve outcomes. The landscape of lung cancer treatment has changed dramatically in recent years with the development of targeted therapies and immunotherapies, meaning that survival rates for newly diagnosed patients may be better than historical statistics suggest.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
